• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ACW 15.8% 3.2¢

ACTINOGEN MEDICAL LIMITED

Actinogen Medical Limited is an Australia-based biotechnology company. The Company is... Actinogen Medical Limited is an Australia-based biotechnology company. The Company is engaged in the development of a therapy for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol. The Company is engaged in the development of its lead compound, Xanamem, as a therapy for Alzheimer’s Disease, Major Depressive Disorder, Fragile X Syndrome, and other neurological diseases where reducing cortisol inside brain cells could have a positive impact. Xanamem’s mechanism of action is to block the production of cortisol inside cells through the inhibition of the 11B-HSD1 enzyme in the brain. Xanamem is designed to get into the brain after it is absorbed in the intestines upon swallowing its capsule. It has studied 11B-HSD1 inhibition by Xanamem in approximately 300 volunteers and patients. The Company conducts a series of Phase II studies in multiple diseases to further confirm and characterize Xanamem’s therapeutic potential.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ACW 03/05/24 22 4.1K
03/05/24 Last post  stormer Comments Created with Sketch.  22  Views Created with Sketch.  4.1K 
ACW 03/05/24 9 2.0K
03/05/24 Last post  HamishM Comments Created with Sketch.  9  Views Created with Sketch.  2.0K 
ACW
News: ACW Actinogen Medical Announces Capital Raising Of Up To A$8.9 Million
03/05/24 0 110
03/05/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  110 
ACW 02/05/24 28 6.7K
02/05/24 Last post  revolution Comments Created with Sketch.  28  Views Created with Sketch.  6.7K 
ACW
News: ACW Actinogen Medical Seeks Trading Halt
01/05/24 0 194
01/05/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  194 
ACW 01/05/24 12 2.6K
01/05/24 Last post  tony123 Comments Created with Sketch.  12  Views Created with Sketch.  2.6K 
ACW 30/04/24 26 8.3K
30/04/24 Last post  JB21 Comments Created with Sketch.  26  Views Created with Sketch.  8.3K 
ACW
News: ACW Enrolment Completed In Actinogen's XanaCIDD Phase 2A Cognition & Depression Trial
22/04/24 0 222
22/04/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  222 

See All Discussions arrow Created with Sketch.

Timeline

Proposed issue of securities - ACW
03 May 09:48
 
Actinogen announces capital raising of up to $8.9 million
03 May 09:48
 
Trading Halt
01 May 09:26
 
ACW March 2024 quarterly activity report & Appendix 4C
30 Apr 17:14
 
ACW completes cognition & depression phase 2 trial enrolment
22 Apr 09:14
 
First patient treated in ACW XanaMIA ph 2b Alzheimers trial
15 Apr 09:05
 
View More arrow Created with Sketch.
(20min delay)
Last
3.2¢
Change
-0.006(15.8%)
Mkt cap ! $74.46M
Open High Low Value Volume
3.0¢ 3.4¢ 2.9¢ $186.2K 6.157M

Buyers (Bids)

No. Vol. Price($)
2 189149 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 621429 4
View Market Depth
Last trade - 15.52pm 03/05/2024 (20 minute delay) ?
Last
3.2¢
  Change
-0.006 ( 11.1 %)
Open High Low Volume
3.0¢ 3.4¢ 2.9¢ 3278602
Last updated 15.52pm 03/05/2024 ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.